leisure time -WSS

leisure time

author：focus 2025-10-01 23:38:37 - browse：5969

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The history of OxyContin, told through Purdue Pharma documents

WSS

Pharma budget tightening trickles down to Doximity

The (many) problems with a new study criticizing cancer screening

House transparency, PBM reform bill gains bipartisan support

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Humana sues Biden admin over Medicare Advantage audit rule

How to protect patients from sexual assault

entertainment

leisure time

entertainment

BioMarin wins approval for gene therapy to treat hemophilia A

Stem cell treatment guidelines are released by FDA

As demand for Covid shots wanes, Moderna seeks its next success

How generative AI is inspiring dreams of a health data revolution

Tori Bowie and the unacceptable rates of Black maternal death

Who are the detained American citizens released from prison in Iran?

Walensky prepares to leave CDC — and Congress — behind

Listen: Your guide to Wegovy's blockbuster heart study

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Stem cell treatment guidelines are released by FDA

hotspot

Crinetics acromegaly drug succeeds in late

Illumina names Agilent executive as new CEO

ALS advocates say criticism of new drugs misses bigger picture

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Genentech weighs delaying cancer therapy after drug pricing law

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

focus

Wikipedia

knowledge

Wikipedia